Capehorn, Matthew
Johansson, Erin https://orcid.org/0009-0006-3178-1622
Davies, Alun
Evans, Jerome
Godbeer, Fiona
van Hest, Naomi
Cotterill, Georgina
Tolley, Keith
Funding for this research was provided by:
This study was funded by Eli Lilly and Company
Article History
Received: 5 March 2025
Accepted: 17 June 2025
First Online: 11 August 2025
Declarations
:
: Erin Johansson, Alun Davies, Jerome Evans, Fiona Godbeer: Employees and shareholders of Eli Lilly and Company; Naomi van Hest, Georgina Cotterill: Employees of Costello Medical, which received payment from Eli Lilly and Company for analytical services for this study. Matthew Capehorn: Received funding for pharmaceutical research and consulting fees for meetings and advisory boards from Eli Lilly, Novo Nordisk and Boehringer; received payment for talks and received support for attending meetings from Eli Lilly and Novo Nordisk. Kieth Tolley has no relevant financial relationships or otherwise to disclose.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.